The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey-Reference-Cited by-同舟云学术

The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey

Published:2014-05-07 Issue:7 Volume:23 Page:925-942
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Aprile Giuseppe¹,Giampieri Riccardo²,Bonotto Marta¹,Bittoni Alessandro²,Ongaro Elena¹,Cardellino Giovanni Gerardo¹,Graziano Francesco³,Giuliani Francesco⁴,Fasola Gianpiero¹,Cascinu Stefano²,Scartozzi Mario²

Affiliation:

1. University and General Hospital, Department of Medical Oncology, Piazzale S Maria della Misericordia 1, 33100, Udine, Italy ; ;

2. Azienda Ospedali Riuniti-Università Politecnica delle Marche, Department of Medical Oncology, Ancona, Italy

3. Azienda Ospedali Riuniti Marche Nord, Department of Onco-Hematology, Pesaro, Italy

4. National Cancer Institute ‘G. Paolo II’, Department of Medical Oncology, Bari, Italy

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.912631

Reference134 articles.

1. Global cancer statistics

2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

3. Cancer statistics, 2014

4. Cancer statistics for Hispanics/Latinos, 2012

5. Advanced gastric cancer – Slow but steady progress

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

2. New Advances in Molecular Typing of Gastric Cancer;Advances in Clinical Medicine;2023

3. Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft;Cell Death Discovery;2022-12-03

4. Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening;Anticancer Research;2022-05-31

5. Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis;Nature Communications;2021-11-04